By binding to sirtuin6 (SIRT6), it promotes acetylation of H3K9ac, a gene related to energy metabolism and upregulates the levels of PDK4, LDHA, and phosphofructokinase-1 (PFK1) in breast cancer cells, thereby promoting metabolic reprogramming in breast cancer. This evidence concerns the gene PDK4 and breast carcinoma.